Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study. [electronic resource]
Producer: 20210202Description: 1986-1996 p. digitalISSN:- 1534-4681
- Adenocarcinoma -- mortality
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Female
- Fluorouracil -- therapeutic use
- Humans
- Internationality
- Irinotecan -- therapeutic use
- Leucovorin -- therapeutic use
- Male
- Middle Aged
- Neoadjuvant Therapy -- methods
- Oxaliplatin -- therapeutic use
- Pancreas -- pathology
- Pancreatectomy -- adverse effects
- Pancreatic Fistula -- epidemiology
- Pancreatic Neoplasms -- mortality
- Postoperative Complications -- epidemiology
- Propensity Score
- Retrospective Studies
- Survival Analysis
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.